menu search

Why novocure stock was sick today

The cancer treatment device developer released its latest set of quarterly results. These were a mixed bag, as it notched a beat on earnings but misse...

October 26, 2023, 4:35 pm

3 things about novocure that smart investors know

novocure doesn't have any direct competitors for its anti-cancer device. The product could see its indi...

September 19, 2023, 10:15 am

Down 31% in 1 day, what's next for novocure stock?

One of NovoCure's late-stage clinical trials didn't turn out well. There are serious questions about the cost effectiveness of its product....

September 4, 2023, 9:30 am

Lifshitz law pllc announces investigations of peloton interactive, inc. (nasdaq: pton), dzs inc. (nasdaq: dzsi), triplepoint venture growth bdc corp. (nyse: tpvg), and novocure ltd. (nasdaq: nvcr)

NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) — Peloton Interactive, Inc. (NASDAQ: PTON) Lifshitz Law PLLC announces investigation into possible securit...

September 2, 2023, 11:00 pm

Why novocure stock fell 24.4% this week

On Monday, novocure announced a key phase 3 trial evaluating its Tumor Treating Fields (TTFields) thera...

August 31, 2023, 6:52 pm

Is novocure's stock headed for a free fall?

NovoCure's treatment for ovarian cancer failed to prove it was effective in a late-stage trial. It's a big blow for a company whose business isn't in ...

August 31, 2023, 9:55 am

novocure shares plunge after its ovarian cancer treatment fails to meet goal

novocure (NVCR) shares plunged 37.5% on Monday after the provider of cancer-fighting treatments reporte...

August 28, 2023, 5:25 pm

Why is novocure (nvcr) stock down 30% today?

Shares of innovative biotechnology firm novocure (NASDAQ: NVCR ) cratered badly, losing 30% on Monday m...

August 28, 2023, 2:53 pm

Why novocure stock is crashing today

NovoCure's tumor treating fields therapy didn't meet the primary endpoint in a phase 3 study targeting ovarian cancer. The company's analysis pointed ...

August 28, 2023, 12:21 pm

novocure stock plummets after phase 3 cancer trial fails to reach desired endpoint

novocure (NASDAQ:NVCR) shares are down nearly a third Monday after a Phase 3 study of its Tumor Treatin...

August 28, 2023, 12:04 pm

novocure shares plunge after ovarian cancer study failure

Shares of novocure Ltd. NVCR, -0.77% dropped 37% premarket on Monday after the Swiss oncology company s...

August 28, 2023, 8:34 am

Novocure's cancer therapy fails to meet main goal in late-stage trial

novocure said on Monday its therapy failed in a late-stage trial to meet the main goal of improving sur...

August 28, 2023, 7:35 am

Could novocure stock help you become a millionaire?

novocure will soon report data from multiple late-stage trials. The company is focused on treating aggr...

August 25, 2023, 8:20 am

Nvcr deadline reminder: bernstein liebhard llp reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit against novocure limited

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP: Do you, or did you, own shares of novocur...

August 14, 2023, 5:45 am

2 incredibly cheap growth stocks to buy in august

Growth stocks have roared back to life after a rough 2022. Confluent and novocure are two high-growth c...

August 9, 2023, 10:45 am

Is novocure stock a buy now?

novocure struggles to stay profitable despite having a product on the market. Penetrating its addressab...

August 9, 2023, 5:10 am

Rosen, a leading national firm, encourages novocure limited investors to secure counsel before important august 18 deadline in securities class action – nvcr

NEW YORK, Aug. 05, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ...

August 5, 2023, 4:58 pm

Nvdr deadline reminder: bernstein liebhard llp reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit against novocure limited

NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP: Do you, or did you, own shares of novocur...

August 1, 2023, 5:45 am

Rosen, a leading investor rights law firm, encourages novocure limited investors to secure counsel before important deadline in securities class action – nvcr

NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ...

August 1, 2023, 12:25 am

Why novocure stock tumbled by nearly 16% today

The cancer-focused biotech published its second-quarter results. These fell short of analyst expectations, unfortunately....

July 27, 2023, 6:56 pm


Search within

Pages Search Results: